Please enable JS

Investors & Media

Event Calendar

Upcoming Events Past Events
May 2018?
Calendar Help
This calendar contains six months of past and future company related information, which may include press releases, SEC filings, calendar events and more. Dates containing information are indicated by a colored background. Please select a highlighted date from the calendar to see date-specific company information, including a link to additional information. This calendar requires JavaScript to be installed and activated on your browser.
Calendar Icon Legend:
Analyst Meeting
Conference
Conference Presentation
Corporate Conference Call
Custom Events
Earnings Conference Call
Earnings Release
Financial Reports
Mergers & Acquisition Announcement
Guidance Announcement
Other Corporate
Sales Call/Presentation
Sales Release
Shareholders Meeting
News Release
SEC Filings
Presentations
52 Week High
Today
SunMonTueWedThuFriSat
-2-112
May-02-2018
4
Formats:  HTML Adobe PDF Word
4
Formats:  HTML Adobe PDF Word
345
6789101112
13141516171819
2021
May-21-2018
4
Formats:  HTML Adobe PDF Word
2223242526
27282930315152
Calendar Instructions
Please select a highlighted date from the calendar to view company related information. This calendar requires JavaScript to be installed and activated on your browser.
Upcoming Events
There are currently no events scheduled.
DateTitle
5/15/18
 2018 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting Poster: Allogeneic CAR-T Cells with Multiple Therapeutically Favorable Edits Can Be Created Efficiently Using CRISPR/Cas9
4/16/18
 2018 American Association for Cancer Research (AACR) Annual Meeting Poster: Allogeneic Chimeric Antigen Receptor T Cells Targeting B Cell Maturation Antigen
4/16/18
 2018 American Association for Cancer Research (AACR) Annual Meeting Poster: Allogeneic CRISPR Engineered Anti-CD70 CAR-T Cells Demonstrate Potent Preclinical Activity Against Both Solid and Hematological Cancer Cells
12/10/17
 2017 American Society of Hematology Annual Meeting Presentation: CRISPR/Cas9 Genome Editing to Treat Sickle Cell Disease and ß-Thalassemia: Re-Creating Genetic Variants to Upregulate Fetal Hemoglobin Appear Well-Tolerated, Effective and Durable
11/10/17
 SITC 2017 Investor Reception Presentation
11/10/17
 Production of Site-specific Allogeneic CAR-T Cells by CRISPR/Cas9 for B-Cell Malignancies
6/23/17
 2017 European Hematology Association Annual Congress Presentation
5/23/17
 UBS Global Healthcare Conference Presentation
5/03/17
 42nd Annual Deutsche Bank Health Care Conference Presentation
4/06/17
 2017 Needham Conference Presentation
12/06/16
 Re-Creating Hereditary Persistence of Fetal Hemoglobin (HPFH) to treat Sickle Cell Disease and ß-thalassemia poster presented at the 2016 American Society of Hematology Annual Meeting
12/06/16
 CRISPR/Cas9-mediated genome editing of Human CD34+ cells upregulate fetal hemoglobin to clinically relevant levels in single cell-derived erythroid colonies poster presented at the 2016 American Society of Hematology Annual Meeting
Print Page E-mail Page RSS Feeds E-mail Alerts IR Contacts Financial Tear Sheet